Echelon Biosciences, Inc (EBI) was founded as Echelon Research Labs by two professors from the University of Utah. Their initial goal was to advance the science of lipid signaling by developing novel research reagents, assays, and ultimately technology leading to drug treatments and diagnostics for debilitating diseases.
Elevating science to enable a healthier world.
Moving science forward with unique products and an adventurous spirit.
We aim to conduct science that benefits both people and our planet.
Echelon Research Labs established as a university spin-out from the University of Utah
Move into new headquarters and rebrand as Echelon Biosciences
Echelon is purchased by the German-Canadian pharmaceutical company Aeterna-Zentaris on the strength of their assay development
Back to Utah
Echelon is acquired by Frontier Scientific, now Frontier Specialty Chemicals, bringing them back as a Utah-based company
Echelon purchases California Peptide to expand catalog offerings and synthesis capabilities
Around the world
Expansion of worldwide distributor network to include markets in South and Southeast Asia
Continuing to grow by partnering with HTL Biotechnology and Gulliver Biomed to expand product offerings in Hyaluronic Acid and Nanobody Production
We continue to work towards solutions in all research spaces as we look to new areas where we can contribute our expertise